A case if infant botulism due to neurotoxigenic Clostridium butyricum type E associated with Clostridium difficile colitis.
Reported here is the sixth case of intestinal toxemia botulism caused by Clostridium butyricum type E in Italy since 1984. In this case, the patient was concomitantly affected with colitis due to Clostridium difficile toxin. A review of previously reported cases revealed that some of these patients may also have had intestinal toxemia botulism associated with Clostridium difficile colitis, based on the reported symptoms. Given that this association has been shown to exist not only in Italy but also in the USA, it is recommended that individuals with intestinal botulism and symptoms of colitis undergo testing for Clostridium difficile and its toxins in fecal samples.
Fenicia
L
L
National Reference Center for Botulism, National Institute of Health, Rome, Italy.
Da Dalt
L
L
Anniballi
F
F
Franciosa
G
G
Zanconato
S
S
Aureli
P
P
D000900:Anti-Bacterial Agents; D001906:Botulism / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology*; D016360:Clostridioides difficile / Q000187:drug effects / Q000302:isolation & purification*; D003014:Clostridium botulinum / Q000145:classification* / Q000187:drug effects / Q000302:isolation & purification; D004359:Drug Therapy, Combination / Q000008:administration & dosage; D004761:Enterocolitis, Pseudomembranous / Q000150:complications* / Q000175:diagnosis / Q000382:microbiology*; D004768:Enterotoxins / Q000009:adverse effects; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D004768:Enterotoxins